Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation (SCr-ED). by M. S. A. Niemantsverdriet (11886431)

Raw data used to calculate the statistical significances stated in the result section. by Tom Adriaenssens (397863)

Subjects:

NN analysis to assign the importance of variables. by Sulmaz Ghahramani (3387635)

Subjects:

Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

“…Samples were separated based on clinical outcome (X-axis, orange treatment responsive, teal treatment non-responsive). …”

Table1_Clinical Significance of TET2 in Female Cancers.docx by Fang Wan (779615)

“…Therefore, this study aimed to summarize the clinical value and underlying oncogenic functions of TET2 in female cancers, such as breast invasive carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), ovarian serous cystadenocarcinoma (OV), uterine corpus endometrial carcinoma (UCEC), and uterine carcinosarcoma (UCS), based on the data obtained from The Cancer Genome Atlas. …”

The significance of variation in cortical trabecular bone stiffness between specimens. by Linje Wang (18064951)

Subjects:

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Subjects:

The significance of variation in cortical bone elastic modulus within a region. by Linje Wang (18064951)

Subjects:

Descriptive statistics based on type of therapy and time of assessment. by Nina Brkić-Jovanović (18886883)

Subjects:

Data for subjects with significant slopes (regional progression or recovery colour coded, non-significant regions white) for the 4 data types over the study period. by Faran Sabeti (6166766)

Subjects:

Quantitative Venn diagram of proteins expressed in sera of patients with clinically significant portal hypertension (CSPH) and non-CSPH group. by Frane Pastrovic (18349349)

Clinical and demographic characteristics of SSc patients and controls. by Jing Mao (148640)

Subjects:

Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Clinical characteristics of the GBM group. by Sang-Soo Choi (11820298)

Subjects:

Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

“…We assessed whether fluconazole resistance had emerged in clinical cryptococcal isolates over a decade.</p><p>Methodology and principal findings</p><p>We prospectively collected <i>C</i>. …”

Classification of injuries based on Delphi consensus. by Ali S. Raja (9465320)

Subjects:

Clinical significance of the prognostic index. by Yue-ling Peng (14636780)

<i>GmNN1/FT2a</i> expression analysis. by Xinxin Li (281237)

Subjects:

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

Subjects: